# Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma

> **NCT07665892** · PHASE1 · RECRUITING · sponsor: **Aspeya, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Safety in Asthma Patients

## Interventions

- **COMBINATION_PRODUCT:** ASY202
- **COMBINATION_PRODUCT:** Placebo

## Key facts

- **NCT ID:** NCT07665892
- **Lead sponsor:** Aspeya, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-26
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07665892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07665892, "Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07665892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*